First-line cetuximab versus bevacizumab for RAS and BRAF...

BMC Cancer 2019 / 12 Vol. 19; Iss. 1

First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis

Zheng, Bobo, Wang, Xin, Wei, Mingtian, Wang, Quan, Li, Jiang, Bi, Liang, Deng, Xiangbing, Wang, Ziqiang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-019-5481-z
Date:
December, 2019
File:
PDF, 1.76 MB
english, 2019
Conversion to is in progress
Conversion to is failed